StartUPDATES: New developments from healthcare startups
Read about new developments from Blue Therapeutics, Docbot, Sema4, and Deep Lens.
Read about new developments from Blue Therapeutics, Docbot, Sema4, and Deep Lens.
The five life sciences IPOs this week continues the steady march companies are making to the public markets this year. This week's activity follows a first quarter that Renaissance Capital calculates was the busiest for newly public companies since 2000. Healthcare IPOs continued to dominate the stock offerings.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
In response to emailed questions, the CEO and CTO talk about the immune intelligence startup's Human Immunity Map — a growing database of immune interactions that can support the development of multiplex diagnostics, vaccines and therapeutics.
Cellino Biotech CEO and Co-founder Dr. Nabiha Saklayen talked about the formation of the company and its goal to make stem cell therapies accessible for patients.
More healthcare startups are choosing to go public through mergers with special-purpose acquisition companies— publicly-traded shell companies created with the purpose of taking a private company public. But as the number of SPACs searching for targets increases, will the SPAC bubble burst?
Check out new developments from healthcare startups including Bind, ChromaCode and more.
Read about new developments and milestones in the journey of healthcare startups from Truvian Sciences, NeuroFlow and more.
Read about new developments from healthcare startups including HealCo, Eikonoklastes, Sidecar Health and more.
MedCity News will host its INVEST conference online the week of July 20. These five biopharma companies will take part in the INVEST Pitch Perfect startup competition.
Higi, a company that makes health kiosks for use in grocery stores, raised $30 million in funding from Babylon Health. Read more about companies that raised funding this week.
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
In an interview with MedCity News, the founder and CSO of Spanish biotech startup Libera Bio talked about her company's ambitions to apply its precision medicine technologies for the treatment of different types of cancer.
Despite continued economic impacts from the Covid-19 pandemic, biotechnology companies and VC firms raised significant amounts of funding this week. For example, Massachusetts-based Pandion Therapeutics closed $80 million in funding to develop a therapeutic designed to treat autoimmune diseases.
The increased patient-centric focus in drug development by the FDA is highly encouraging and expected to become more mainstream and legislated.
A new eBook from MedCity News spotlights some of the more interesting deals and trends this year across digital health and biopharma.
At the intersection of technology and medicine, the Digital Medicine & Medtech Showcase will offer more than 70 dedicated company presentations and 500+ attendees exclusively from the digital medicine and medtech sectors.